Skip to main content
. Author manuscript; available in PMC: 2018 Apr 9.
Published in final edited form as: Bone Marrow Transplant. 2017 Oct 9;52(12):1629–1636. doi: 10.1038/bmt.2017.197

Figure 1. Relapse-free and overall survival for all patients.

Figure 1

Kaplan-Meier estimates of (A) relapse-free survival and (B) overall survival for the entire cohort, measured in years after the 1-year landmark. Estimated 5-year RFS was 73% (95% CI 67–78%), and estimated 5-year OS was 76% (95% CI 70–81%).